Neonatal Respiratory Distress Syndrome: Tackling A Worldwide Problem.
作者信息
Dyer Janet
出版信息
P T. 2019 Jan;44(1):12-14.
Abstract
摘要
相似文献
1
Neonatal Respiratory Distress Syndrome: Tackling A Worldwide Problem.
P T. 2019 Jan;44(1):12-14.
2
Scenario of Neonatal Respiratory Distress in Tertiary Hospital.
J Nepal Health Res Counc. 2018 Jul 3;16(2):131-135.
3
A novel approach to study oxidative stress in neonatal respiratory distress syndrome.
BBA Clin. 2014 Dec 8;3:65-9. doi: 10.1016/j.bbacli.2014.12.001. eCollection 2015 Jun.
4
[Do antenatal corticosteroids in term elective cesarean sections reduce neonatal respiratory morbidity?].
Medwave. 2015 Oct 7;15(9):e6280. doi: 10.5867/medwave.2015.09.6280.
5
Umbilical cord blood and neonatal endothelin-1 levels in preterm newborns with and without respiratory distress syndrome.
Braz J Med Biol Res. 2005 Sep;38(9):1417-22. doi: 10.1590/s0100-879x2005000900017. Epub 2005 Aug 26.
6
Postnatal thyroid hormones for respiratory distress syndrome in preterm infants.
Cochrane Database Syst Rev. 2007 Jan 24(1):CD005946. doi: 10.1002/14651858.CD005946.pub2.
7
Primary ciliary dyskinesia and neonatal respiratory distress.
Pediatrics. 2014 Dec;134(6):1160-6. doi: 10.1542/peds.2014-0808.
8
Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.
Drugs. 1989 Oct;38(4):591-611. doi: 10.2165/00003495-198938040-00006.
9
Respiratory distress in neonates with special reference to pneumonia.
Indian Pediatr. 2002 Jun;39(6):529-37.
10
Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
Drugs. 1991 Nov;42(5):877-94. doi: 10.2165/00003495-199142050-00009.
引用本文的文献
1
Comparative Efficacy and Safety Profile of the Combination of Pulmonary Surfactant and Budesonide vs. Surfactant Alone in the Management of Neonatal Respiratory Distress Syndrome: An Updated Meta-Analysis.
Medicina (Kaunas). 2025 Jul 23;61(8):1329. doi: 10.3390/medicina61081329.
2
Storage and in-use stability of an excipient enhanced growth (EEG) synthetic lung surfactant powder formulation.
Drug Dev Ind Pharm. 2025 Jul;51(7):747-757. doi: 10.1080/03639045.2025.2508845. Epub 2025 May 26.
3
A short-course of low-dose insulin detemir effectively decreases blood glucose levels in gestational diabetic women undergoing dexamethasone treatment to promote newborn lung maturity.
Medicine (Baltimore). 2025 Jan 17;104(3):e40547. doi: 10.1097/MD.0000000000040547.
4
c.838C>T (p.Arg280Cys, R280C) and c.697C>T (p.Gln233Ter, Q233X, Q233*) as Causative Variants for RDS: A Family Case Study and Literature Review.
Biomedicines. 2024 Oct 18;12(10):2390. doi: 10.3390/biomedicines12102390.
5
Clinical cause of neonatal mortality in Iran: analysis of the national Iranian Maternal And Neonatal network.
BMJ Paediatr Open. 2024 Mar 20;8(1):e002315. doi: 10.1136/bmjpo-2023-002315.
6
Descriptive and Functional Genomics in Neonatal Respiratory Distress Syndrome: From Lung Development to Targeted Therapies.
Int J Mol Sci. 2024 Jan 4;25(1):649. doi: 10.3390/ijms25010649.
7
Non-invasive ventilation in neonates: a review of current literature.
Front Pediatr. 2023 Nov 28;11:1248836. doi: 10.3389/fped.2023.1248836. eCollection 2023.
8
Prevalence and Missed Cases of Respiratory Distress Syndrome Disease Amongst Neonatal Deaths Enrolled in the Kenya Child Health and Mortality Prevention Surveillance Network (CHAMPS) Program Between 2017 and 2021.
Glob Pediatr Health. 2023 Dec 5;10:2333794X231212819. doi: 10.1177/2333794X231212819. eCollection 2023.
9
Incidence and predictors of respiratory distress syndrome among low birth weight neonates in the first seven days in Northwest Ethiopia Comprehensive Specialized Hospitals, 2023: A retrospective follow-up study.
BMJ Open. 2023 Nov 19;13(11):e079063. doi: 10.1136/bmjopen-2023-079063.
10
Feasibility of a novel ultra-low-cost bubble CPAP (bCPAP) System for neonatal respiratory support at Muhimbili National Hospital, Tanzania.
PLoS One. 2022 Dec 30;17(12):e0269147. doi: 10.1371/journal.pone.0269147. eCollection 2022.
本文引用的文献
1
Updates on the Status of Vitamin D as a Risk Factor for Respiratory Distress Syndrome.
Adv Pharmacol Sci. 2018 Sep 30;2018:8494816. doi: 10.1155/2018/8494816. eCollection 2018.
2
Less is More: Modern Neonatology.
Rambam Maimonides Med J. 2018 Jul 30;9(3):e0023. doi: 10.5041/RMMJ.10344.
3
Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial.
Arch Dis Child Fetal Neonatal Ed. 2019 May;104(3):F313-F319. doi: 10.1136/archdischild-2018-315051. Epub 2018 Jul 26.
4
Preterm Neonates with Respiratory Distress Syndrome: Ventilator-Induced Lung Injury and Oxidative Stress.
J Immunol Res. 2018 Apr 23;2018:6963754. doi: 10.1155/2018/6963754. eCollection 2018.
5
Treatment Patterns and Clinical Outcomes in Neonates Diagnosed With Respiratory Distress Syndrome in a Low-Income Country: A Report From Bangladesh.
Anesth Analg. 2018 May;126(5):1684-1686. doi: 10.1213/ANE.0000000000002865.
6
Inhaled Nitric Oxide in Extremely Premature Neonates With Respiratory Distress Syndrome.
Pediatrics. 2018 Mar;141(3). doi: 10.1542/peds.2017-3108. Epub 2018 Feb 9.
7
8
Respiratory distress syndrome in preterm infants and risk of epilepsy in a Danish cohort.
Eur J Epidemiol. 2018 Mar;33(3):313-321. doi: 10.1007/s10654-017-0308-1. Epub 2017 Sep 8.
9
Ventilation in Extremely Preterm Infants and Respiratory Function at 8 Years.
N Engl J Med. 2017 Jul 27;377(4):329-337. doi: 10.1056/NEJMoa1700827.
10
Surfactant for Respiratory Distress Syndrome: New Ideas on a Familiar Drug with Innovative Applications.
Neonatology. 2017;111(4):408-414. doi: 10.1159/000458466. Epub 2017 May 25.
Zotero 插件